Skip to main content
. Author manuscript; available in PMC: 2007 Sep 20.
Published in final edited form as: Pharmacogenet Genomics. 2006 Aug;16(8):537–545. doi: 10.1097/01.fpc.0000215071.59836.29

Table 7.

Association between history of cigarette smoking and risk of NHL by NAT1*10 and NAT2 phenotype.

NAT1*any(except *10)/*any(except *10) NAT1*10/any(except *10) | NAT1*10/*10


Controls N(%) Cases N(%) OR (95% CI)* P Controls N(%) Cases N(%) OR(95% CI)* p

Nonsmokers 85(18.7) 102(18.6) 1.00 (reference) 43(14.7) 62(16.8) 1.00 (reference)
Current smokers 30(6.6) 42(7.7) 1.12 (0.64, 1.95) 0.7 14(4.8) 28(7.6) 1.32 (0.62, 2.84) 0.5
Former smokers 78(17.2) 74(13.5) 0.86 (0.55, 1.33) 0.5 36(12.3) 46(12.5) 0.85 (0.47, 1.56) 0.6
Missing 261(57.5) 329(60.1) 1.11 (0.79, 1.57) 0.6 199(68.2) 233(63.1) 0.95 (0.60, 1.49) 0.8

NAT2 Slow Intermediate/Rapid


Controls N(%) Cases N(%) OR (95% CI)* p Controls N(%) Cases N(%) OR(95% CI)* p

Nonsmokers 82(18.1) 93(17.8) 1.00 (reference) 60(16.9) 88(19.0) 1.00 (reference)
Current smokers 34(7.5) 36(6.9) 0.87 (0.50, 1.53) 0.6 11(3.1) 38(8.2) 2.44 (1.15, 5.20) 0.02
Former smokers 70(15.5) 75(14.3) 0.99 (0.63, 1.55) 0.9 56(15.7) 57(12.3) 0.70 (0.42, 1.15) 0.2
Missing 266(15.5) 319(61.0) 1.06 (0.74, 1.50) 0.8 229(64.3) 279(60.4) 1.03 (0.70, 1.52) 0.9
*

OR (95% CI) adjusted for age, sex, race, and study center.